In a randomized , double-blind , placebo-controlled , parallel phase @ , efficacy and safety study , eligible patients with moderate to severe LUTS and prostatic enlargement ( @ml ) were randomized to placebo or LY@ at @ , @ , @ and @mg once daily for @ weeks .